Outcomes after reversed corneal graft rejection: a report from the European VISICORT project
Objective This study aims to describe the outcome of corneal grafts, both low risk and high risk, after successfully reversed immunological rejection.Methods Datasets on reversed rejection episodes in penetrating and endothelial keratoplasties between 2014 and 2019 (n=876) were extracted from the Ad...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001554.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832087011275571200 |
---|---|
author | W John Armitage Uwe Pleyer Conor C Murphy Derek Tole Matthew D Griffin Jesper Hjortdal Katja C Iselin Bertrand Vabres |
author_facet | W John Armitage Uwe Pleyer Conor C Murphy Derek Tole Matthew D Griffin Jesper Hjortdal Katja C Iselin Bertrand Vabres |
author_sort | W John Armitage |
collection | DOAJ |
description | Objective This study aims to describe the outcome of corneal grafts, both low risk and high risk, after successfully reversed immunological rejection.Methods Datasets on reversed rejection episodes in penetrating and endothelial keratoplasties between 2014 and 2019 (n=876) were extracted from the Adverse Immune Signatures and their Prevention in Corneal Transplantation database, which contains the prospectively and consecutively collected corneal transplants from five European centres. Stratified by the preoperatively determined risk status for immunological rejection, the outcome parameters analysed included visual acuity, intraocular pressure, endothelial cell density and central corneal thickness before and after reversed rejection episodes.Results Fourty-seven (52%) out of a total of 91 identified rejection episodes were successfully reversed and were available for analysis (23 penetrating and 24 endothelial keratoplasties). No statistically significant change was found for any of the parameters studied between the values before and the values 3 months after the rejection episode, irrespective of the preoperative risk status.Conclusion The outcome of corneal grafts that survive immunological rejection may be clinically indistinguishable from the state before immunological rejection, irrespective of graft type and risk status. These findings support clinicians by providing information on prognosis after reversed rejection episodes and by giving patients realistic expectations regarding the outcome. |
format | Article |
id | doaj-art-3b3315d30ec849698f9c3d477908a086 |
institution | Kabale University |
issn | 2397-3269 |
language | English |
publishDate | 2024-04-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open Ophthalmology |
spelling | doaj-art-3b3315d30ec849698f9c3d477908a0862025-02-06T08:20:15ZengBMJ Publishing GroupBMJ Open Ophthalmology2397-32692024-04-019110.1136/bmjophth-2023-001554Outcomes after reversed corneal graft rejection: a report from the European VISICORT projectW John Armitage0Uwe Pleyer1Conor C Murphy2Derek Tole3Matthew D Griffin4Jesper Hjortdal5Katja C Iselin6Bertrand Vabres7Department of Ophthalmology, Bristol University, Bristol, UKDepartment of Ophthalmology, Charité Universitätsmedizin Berlin, Berlin, GermanyRoyal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin, IrelandDepartment of Ophthalmology, Bristol University, Bristol, UKRegenerative Medicine Institute (REMEDI), CÚRAM SFI Centre for Research in Medical Devices, School of Medicine, National University of Ireland Galway, Galway, IrelandDepartment of Ophthalmology, Aarhus University Hospital, Aarhus, DenmarkRoyal College of Surgeons in Ireland (RCSI), University of Medicine and Health Sciences, Dublin, IrelandDepartment of Ophthalmology, Centre hospitalier universitaire de Nantes, Nantes, FranceObjective This study aims to describe the outcome of corneal grafts, both low risk and high risk, after successfully reversed immunological rejection.Methods Datasets on reversed rejection episodes in penetrating and endothelial keratoplasties between 2014 and 2019 (n=876) were extracted from the Adverse Immune Signatures and their Prevention in Corneal Transplantation database, which contains the prospectively and consecutively collected corneal transplants from five European centres. Stratified by the preoperatively determined risk status for immunological rejection, the outcome parameters analysed included visual acuity, intraocular pressure, endothelial cell density and central corneal thickness before and after reversed rejection episodes.Results Fourty-seven (52%) out of a total of 91 identified rejection episodes were successfully reversed and were available for analysis (23 penetrating and 24 endothelial keratoplasties). No statistically significant change was found for any of the parameters studied between the values before and the values 3 months after the rejection episode, irrespective of the preoperative risk status.Conclusion The outcome of corneal grafts that survive immunological rejection may be clinically indistinguishable from the state before immunological rejection, irrespective of graft type and risk status. These findings support clinicians by providing information on prognosis after reversed rejection episodes and by giving patients realistic expectations regarding the outcome.https://bmjophth.bmj.com/content/9/1/e001554.full |
spellingShingle | W John Armitage Uwe Pleyer Conor C Murphy Derek Tole Matthew D Griffin Jesper Hjortdal Katja C Iselin Bertrand Vabres Outcomes after reversed corneal graft rejection: a report from the European VISICORT project BMJ Open Ophthalmology |
title | Outcomes after reversed corneal graft rejection: a report from the European VISICORT project |
title_full | Outcomes after reversed corneal graft rejection: a report from the European VISICORT project |
title_fullStr | Outcomes after reversed corneal graft rejection: a report from the European VISICORT project |
title_full_unstemmed | Outcomes after reversed corneal graft rejection: a report from the European VISICORT project |
title_short | Outcomes after reversed corneal graft rejection: a report from the European VISICORT project |
title_sort | outcomes after reversed corneal graft rejection a report from the european visicort project |
url | https://bmjophth.bmj.com/content/9/1/e001554.full |
work_keys_str_mv | AT wjohnarmitage outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT uwepleyer outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT conorcmurphy outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT derektole outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT matthewdgriffin outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT jesperhjortdal outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT katjaciselin outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject AT bertrandvabres outcomesafterreversedcornealgraftrejectionareportfromtheeuropeanvisicortproject |